XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Investments (Tables)
 9 Months Ended
Sep. 30, 2022
Investments Explanatory [Abstract]  
Schedule of investments
($000s)  January 1, 2022   Fair value through other comprehensive income (loss)   Loss of associate   Impairment   Additions   September 30, 2022 
Current assets:                        
Investments in marketable securities   3,367    (72)   
-
    
-
    
-
    3,295 
                               
Non-current assets:                              
Investment in associate   2,429    
-
    (142)   (873)(a)   39(b)   1,453 

 

($000s)  January 1,
2021		   Fair value
through other
comprehensive
income (loss)		   Loss of
associate		   Impairment   Additions   December 31,
2021		 
Current assets:                        
Investments in marketable securities   3,826    (459)   
-
    
-
    
-
    3,367 
                               
Non-current assets:                              
Investment in associate   2,611    
-
    (221)        39(c)   2,429 

 

(a)The Company accounts for its investment in Paramount, a publicly listed company, using the equity method. During the second quarter of 2022, the Company concluded that the fair value of its investment in Paramount, determined based on the closing share price on June 30, 2022, had declined significantly and recorded an impairment of $0.9 million (December 31, 2021- nil) in the consolidated statements of operations and comprehensive income (loss).
(b)In 2022, the Company received 55,322 common shares of Paramount for payment of interest on the secured convertible notes accrued between July 1, 2021 and June 30, 2022.
(c)During the year ended December 31, 2021, the Company received 30,086 common shares of Paramount for payment of interest on the secured convertible notes accrued between July 1, 2020 and June 30, 2021. Refer to note 7 for details on convertible notes receivable.